• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊姑息治疗环境中头颈部及上消化道以外晚期癌症成人患者的吞咽障碍、生存率和功能:一项前瞻性队列研究

Swallowing Disorders, Survival and Functionality in Adults with Advanced Cancer Outside the Head and Neck and Upper Gastrointestinal Tract in Outpatient Palliative Care Setting: A Prospective Cohort Study.

作者信息

Silva Danielle Nunes Moura, Jardim Yohane Cristina Guimarães, Vicente Laélia Cristina Caseiro, de Lima Friche Amélia Augusta

机构信息

Department of Speech-Language Pathology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

Oncoclinicas/MedSir, Belo Horizonte, MG, Brazil.

出版信息

Dysphagia. 2025 Sep 13. doi: 10.1007/s00455-025-10876-6.

DOI:10.1007/s00455-025-10876-6
PMID:40940622
Abstract

In palliative care, there is still a lack of data regarding the relationship between survival, symptoms, and functionality. To investigate the relationship between functionality and both dysphagia-progression-free survival and overall survival in patients with advanced cancer. A prospective cohort conducted between March 2022 and August 2023. The study was conducted with patients with advanced cancer outside the head and neck and upper gastrointestinal tract, followed by an outpatient palliative care team. Sociodemographic, psychosocial, clinical, functional, and nutritional data were analyzed. A speech therapy evaluation was performed to classify swallowing disorders and the feeding route associated with swallowing ability. Two cohorts were analyzed according to functionality. 39 individuals were eligible, the majority being female. Lower functionality was a significant risk factor for mortality (p < 0.05), with a 4.31-fold increased risk of death. Minimal swallowing declines were associated with worse survival in patients with poorer functionality in univariable analysis (p = 0.01), but this association was not observed in multivariable analysis. Declining functionality was identified as a significant risk factor for mortality. Swallowing ability revealed a negative impact on survival in univariable analysis, however this association was not confirmed in the multivariable model. Likewise, dysphagia-progression-free survival was shorter among patients with poorer functionality, although this was not statistically significant in multivariable analysis. These findings underscore the need for further investigation.

摘要

在姑息治疗中,关于生存、症状和功能之间的关系仍然缺乏数据。为了研究晚期癌症患者的功能与无吞咽困难进展生存期及总生存期之间的关系。于2022年3月至2023年8月进行了一项前瞻性队列研究。该研究针对的是头颈部和上消化道以外的晚期癌症患者,由门诊姑息治疗团队进行随访。分析了社会人口统计学、心理社会、临床、功能和营养数据。进行了言语治疗评估,以对吞咽障碍和与吞咽能力相关的进食途径进行分类。根据功能对两个队列进行了分析。39人符合条件,大多数为女性。功能较低是死亡的一个显著危险因素(p < 0.05),死亡风险增加4.31倍。在单变量分析中,吞咽功能的最小下降与功能较差患者的较差生存期相关(p = 0.01),但在多变量分析中未观察到这种关联。功能下降被确定为死亡的一个显著危险因素。在单变量分析中,吞咽能力对生存有负面影响,然而在多变量模型中这种关联未得到证实。同样,功能较差的患者无吞咽困难进展生存期较短,尽管在多变量分析中这没有统计学意义。这些发现强调了进一步研究的必要性。

相似文献

1
Swallowing Disorders, Survival and Functionality in Adults with Advanced Cancer Outside the Head and Neck and Upper Gastrointestinal Tract in Outpatient Palliative Care Setting: A Prospective Cohort Study.门诊姑息治疗环境中头颈部及上消化道以外晚期癌症成人患者的吞咽障碍、生存率和功能:一项前瞻性队列研究
Dysphagia. 2025 Sep 13. doi: 10.1007/s00455-025-10876-6.
2
Swallowing ability, nutritional status, and functioning in adults with advanced cancer excluding head, neck, and upper gastrointestinal tract: a cross-sectional study in an outpatient palliative care setting.
Codas. 2025 Aug 22;37(4):e20240210. doi: 10.1590/2317-1782/e20240210pt. eCollection 2025.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial.哌甲酯与安慰剂治疗晚期癌症患者疲劳的疗效比较:MePFAC随机对照试验
Health Technol Assess. 2025 Jul;29(36):1-47. doi: 10.3310/GJPS6321.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

本文引用的文献

1
Outpatient Palliative Care Program: Impact on Home Death Rate in Brazil.门诊姑息治疗项目:对巴西家庭死亡率的影响。
Cancers (Basel). 2024 Mar 31;16(7):1380. doi: 10.3390/cancers16071380.
2
Swallowing disorders and mortality in adults with advanced cancer outside the head and neck and upper gastrointestinal tract: a systematic review.晚期头颈部和上消化道外癌症成人的吞咽障碍与死亡率:系统评价。
BMC Palliat Care. 2023 Oct 6;22(1):150. doi: 10.1186/s12904-023-01268-4.
3
Nutrition impact symptoms: Noteworthy prognostic indicators for lung cancer.
营养影响症状:肺癌的显著预后指标。
Clin Nutr. 2023 Apr;42(4):550-558. doi: 10.1016/j.clnu.2023.02.021. Epub 2023 Feb 24.
4
Prevalence of Oropharyngeal Dysphagia in Adults in Different Healthcare Settings: A Systematic Review and Meta-analyses.不同医疗保健环境下成人口咽吞咽困难的患病率:系统评价和荟萃分析。
Dysphagia. 2023 Feb;38(1):76-121. doi: 10.1007/s00455-022-10465-x. Epub 2022 May 31.
5
Molecular and Neural Mechanism of Dysphagia Due to Cancer.癌症相关性吞咽障碍的分子与神经机制。
Int J Mol Sci. 2021 Jun 29;22(13):7033. doi: 10.3390/ijms22137033.
6
Palliative Performance Scale and survival in patients with cancer and non-cancer diagnoses needing a palliative care consultation: a retrospective cohort study.癌症和非癌症诊断患者的姑息治疗咨询需求的姑息治疗表现量表和生存:一项回顾性队列研究。
BMC Palliat Care. 2021 May 26;20(1):74. doi: 10.1186/s12904-021-00773-8.
7
Prognostic tools for survival prediction in advanced cancer patients: A systematic review.晚期癌症患者生存预测的预后工具:系统评价。
J Med Imaging Radiat Oncol. 2021 Oct;65(6):806-816. doi: 10.1111/1754-9485.13185. Epub 2021 May 10.
8
Efficacy of speech therapy in post-intubation patients with oropharyngeal dysphagia: a randomized controlled trial.经气管插管患者并发咽喉部吞咽困难的语言治疗效果:一项随机对照试验。
Codas. 2021 Apr 26;33(2):e20190246. doi: 10.1590/2317-1782/20202019246. eCollection 2021.
9
Symptom perception and functioning in patients with advanced cancer.晚期癌症患者的症状感知和功能。
PLoS One. 2021 Feb 4;16(2):e0245987. doi: 10.1371/journal.pone.0245987. eCollection 2021.
10
Dysphagia prevalence and associated survival differences in older patients with lung cancer: A SEER-Medicare population-based study.老年肺癌患者吞咽困难的患病率及相关生存差异:一项基于监测、流行病学和最终结果(SEER)-医疗保险人群的研究
J Geriatr Oncol. 2020 Sep;11(7):1115-1117. doi: 10.1016/j.jgo.2020.02.015. Epub 2020 Mar 11.